Zero Johnson & Johnson COVID-19 vaccine doses set to ship next week as production holdup lingers

Johnson & Johnson’s COVID-19 vaccine ran into a big setback in late March when U.S. officials paused the rollout to investigate rare blood clots. While that issue has been resolved with a new warning about the rare risk, the company’s shot is running into another type of pause—a lack of supply.